Pharma and Life Sciences Consulting

Contact Protiviti Australia for expert life sciences consulting

The complexity of risks facing life sciences and pharmaceutical companies is greater than ever before. From IP protection to areas such as drug pricing, reduced funding for all but specific biotechnology research, tax reform, supply chain challenges and tariffs, we understand the impact these risks have on how life sciences and pharmaceutical companies do business.

Protiviti provides life sciences consulting services in Australia, supporting pharmaceutical, biotechnology and medical device organisations to navigate regulatory complexity, manage risk, and scale operations.

We help organisations move from R&D through to commercialisation, improving operational efficiency, strengthening compliance, and enabling growth in a highly regulated environment.

In today’s rapidly evolving environment, a trusted advisor who not only provides relevant insights but delivers a combination of strategic vision, proven expertise and practical experience can enhance the value of your business.

Our experts provide industry-specific solutions tailored to the unique needs of the Australian organisation’s in the following areas:

Technology strategy and operations and software services

Companies often make limited investments within IT, as investments are primarily focused on R&D activities and funding clinical trials. We help emerging companies develop and implement road maps for success by supporting digital transformation in life sciences, including IT strategy, system modernisation, and scalable platforms for clinical and commercial operations.

Supply chain and operations solutions

The pandemic has put broad pressure on the global supply chain due to both an overwhelming demand for select supplies, as well as reduced workforce availability and global trade challenges. We help our clients build resiliency into their operations.

Cybersecurity and privacy services

As more systems move to virtual environments, the risk of cyber threats and liabilities grows. We help build a comprehensive cybersecurity strategy to protect intellectual property, clinical trial data, employee data and patient information from theft or misuse.

Public company transformation services

Making the leap from an R&D-focused organisation to a commercial organisation requires the right combination of resources, processes and technology. We support a commercial launch and also scale to support organisational growth with our proven PCT and SOX programs.

Why do Australian pharma and life sciences companies choose consulting services?

The pharma and life sciences industry is evolving rapidly due to changing regulations, digital transformation, cybersecurity risks, supply chain disruption, pricing pressures and increasing expectations around patient outcomes. Organisations across pharmaceuticals, biotechnology, medical devices and contract research must balance innovation with compliance and operational resilience.

At Protiviti Australia, our life sciences consulting services help organisations strengthen governance, manage risk, improve operational efficiency and accelerate transformation across the value chain. We work with pharmaceutical manufacturers, biotech firms, medical device companies and healthcare innovators to address business-critical challenges.